• Fate Therapeutics, Inc. (NASDAQ:FATE) Director Acquires $668,579.52 in Stock

    المصدر: Buzz FX / 26 ديسمبر 2024 21:16:13   America/Chicago


    Fate Therapeutics, Inc. (NASDAQ:FATE) Director Acquires $668,579.52 in Stock Written by MarketBeat December 26, 2024 Share Link copied to clipboard. Fate Therapeutics, Inc. ( NASDAQ:FATE - Get Free Report ) Director Redmile Group, Llc acqui
    Read more...
شارك على،